Gene-activity Test decides who Can Skip Chemotherapy
However, these studies involved fewer patients than the current study, which enrolled 10,253 women with a certain kind of breast cancer known as hormone-receptor positive, HER2 negative cancer.
Posted On Sep 29 2015